Switching from Ustekinumab to Risankizumab Improves Outcomes in Crohn's Disease: A Single-Centre Real-World Data Analysis

被引：0
|
作者：
Qazi, U. [1 ]
Padley, J. [1 ]
Colwill, M. [1 ,2 ]
Mehta, S. [1 ]
Donovan, F. [1 ]
Alves, A. M. Francisco [1 ]
Pollok, R. [1 ,2 ]
Poullis, A. [1 ,2 ]
Patel, K. [1 ]
Honap, S. [1 ,3 ]
机构：
[1] St Georges Univ Hosp NHS Fdn Trust, Gastroenterol, London, England
[2] City St Georges Univ London, Inst Infect & Immun, London, England
[3] Kings Coll London, Sch Immunol & Microbial Sci, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1269
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1095
引用
收藏
页码：i2012 / i2012
页数：1
相关论文
共 50 条
  • [1] OUTCOMES OF USTEKINUMAB IN CROHN'S DISEASE: THE REAL-WORLD EXPERIENCE OF A TERTIARY IBD CENTRE
    Miller, Bethany
    Stansfield, Catherine
    Korani, Mohamed
    Nixon, Emma
    GUT, 2021, 70 : A108 - A109
  • [2] Treatment patterns, persistence with therapy, and outcomes of ustekinumab in Crohn's disease: Real-world data analysis
    Banon, Tamar
    Weil, Clara
    Borsi, Andras
    Chodick, Gabriel
    Shakked, Zehavi
    Ben-David, Nava Barit
    JGH OPEN, 2022, 6 (02): : 120 - 125
  • [3] Ustekinumab in Crohn's disease: real-world outcomes and predictors of response
    Lorenzo Gonzalez, Laura
    Valdes Delgado, Teresa
    Vazquez Moron, Juan Maria
    Castro Laria, Luisa
    Leo Carnerero, Eduardo
    Maldonado Perez, Maria Belen
    Sanchez Capilla, Damian
    Pallares Manrique, Hector
    Saez Diaz, Antonia
    Arguelles Arias, Federico
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (05) : 272 - 279
  • [4] Risankizumab Effectiveness in Ustekinumab-naive and Ustekinumab-experienced Patients with Crohn's Disease- Real-world Data from a Large Tertiary Center
    Zinger, A.
    Choi, D.
    Choi, N.
    Fear, E.
    Fine, Z.
    Cohen, R. D.
    Dalal, S. R.
    Cleveland, N. Krugliak
    Pekow, J.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1565 - I1565
  • [5] Switching to Biktarvy: real-world single-centre outcomes over 3 years
    King, Lisa
    Mackie, Nicola
    Foster, Caroline
    HIV MEDICINE, 2023, 24 : 26 - 26
  • [6] USTEKINUMAB TREATMENT STRATEGIES IN REFRACTORY CROHN'S DISEASE: REAL-WORLD EFFECTIVENESS DATA FROM A UK IBD CENTRE
    Harris, Richard
    McDonnell, Martin
    Bettey, Marion
    Downey, Louise
    Young, David
    Felwick, Richard
    Gwiggner, Markus
    Cummings, Fraser
    GUT, 2019, 68 : A72 - A73
  • [7] Real-world effectiveness and safety of Risankizumab in Crohn's Disease
    Mcshane, C.
    Olivera Sendra, P. A.
    Kim, J.
    Milgrom, R.
    Stempak, J.
    Nguyen, G.
    Weizman, A., V
    Croitoru, K.
    Gallinger, Z.
    Huang, V
    Steinhart, H.
    Targownik, L.
    Lee, S. H.
    Silverberg, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I2023 - I2024
  • [8] Ustekinumab therapy after biologic failure in patients with Crohn's Disease - A real-world single centre experience
    Majumder, S.
    Bazarova, A.
    Parigi, T. Lorenzo
    Love, M.
    Davis, J.
    Ghosh, S.
    Iacucci, M.
    Shivaji, U. N.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 832 - 832
  • [9] USTEKINUMAB THERAPY AFTER BIOLOGIC FAILURE IN PATIENTS WITH CROHN'S DISEASE -A REAL-WORLD SINGLE CENTRE EXPERIENCE
    Majumder, Snehali
    Bazarova, Alina
    Parigi, Tommaso Lorenzo
    Love, Melanie
    Davis, Joanne
    Ghosh, Subrata
    Iacucci, Marietta
    Shivaji, Uday N.
    GUT, 2022, 71 : A57 - A57
  • [10] Endoscopic Response to Risankizumab in Patients With Refractory Crohn's Disease Who Failed Ustekinumab - Real-World Experience
    Patel, Parth B.
    Banerjee, Debdeep
    Norwood, Dalton A.
    Ismail, Mohamed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S851 - S851
12345